In this project we analyze how a government healthcare provider should negotiate a risk-sharing contract with pharmaceutical drug manufacturers. The objective of the study is to examine how a government healthcare payer should set the terms of pay-for-performance contracts with multiple drug or pharmaceutical manufacturers. The study builds on existing work by Mahjoub, Odegaard, and […]
Read More